Today, the U.S. Food and Drug Administration (FDA) approved letermovir (Prevymis) once-daily tablets for oral use and injection for intravenous infusion. Letermovir…
Uncategorized
FDA Approves Libtayo® (cemiplimab-rwlc) Monotherapy for Patients with First-line Advanced Non-small Cell Lung Cancer with PD-L1 Expression of ≥50% Regeneron…
A new way to help the body’s immune system get past that deception and destroy cancer, has been found by…
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Lorem ipsum dolor sit ametcon sectetur adipisicing elit, sed doiusmod tempor incidi labore et dolore agna aliqua. Ut enim ad mini veniam, quis nostrud
Lorem ipsum dolor sit ametcon sectetur adipisicing elit, sed doiusmod tempor incidi labore et dolore agna aliqua. Ut enim ad mini veniam, quis nostrud
Lorem ipsum dolor sit ametcon sectetur adipisicing elit, sed doiusmod tempor incidilabore
Lorem ipsum dolor sit ametcon sectetur adipisicing elit, sed doiusmod tempor incidilabore
Lorem ipsum dolor sit ametcon sectetur adipisicing elit, sed doiusmod tempor incidilabore
Lorem ipsum dolor sit ametcon sectetur adipisicing elit, sed doiusmod tempor incidilabore